Pliant Therapeutics
PLRX
PLRX
151 hedge funds and large institutions have $725M invested in Pliant Therapeutics in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1.48% less ownership
Funds ownership: 105.91% → 104.43% (-1.5%)
74% less call options, than puts
Call options by funds: $1.3M | Put options by funds: $4.99M
Holders
151
Holding in Top 10
5
Calls
$1.3M
Puts
$4.99M
Top Buyers
| 1 | +$34.8M | |
| 2 | +$6.25M | |
| 3 | +$3.36M | |
| 4 |
BlackRock
New York
|
+$2.77M |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$2.65M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$10.8M | |
| 3 | -$9.26M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$8.15M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.44M |